Phase II Study of Hyper-CVAD Plus Nelarabine in Previously Untreated Adult T-Cell Acute Lymphoblastic Leukemia and T-Lymphoblastic Lymphoma

Yasmin Abaza,Alessandra Ferrajoli,Stefan Faderl,Hagop M Kantarjian,Marina Konopleva,Tapan M Kadia,William G Wierda,Rebecca Garris,Gautam Borthakur,Prithviraj Bose,Nitin Jain,Naveen Pemmaraju,Farhad Ravandi,Philip A Thompson ,Guillermo Garcia‐Manero ,Jorge E Cortés ,Elias Jabbour ,Jan A Burger ,Steven M Kornblau ,Susan O’brien ,Deborah A Thomas ,Mary Ann Kelly

doi:10.1182/blood.v128.22.177.177

Phase II Study of Hyper-CVAD Plus Nelarabine in Previously Untreated Adult T-Cell Acute Lymphoblastic Leukemia and T-Lymphoblastic Lymphoma

Yasmin Abaza, Alessandra Ferrajoli + Show 20 more

Open Access

https://doi.org/10.1182/blood.v128.22.177.177

Copy DOI

Journal: Blood	Publication Date: Dec 2, 2016
Citations: 2

Affiliation: The University of Texas MD Anderson Cancer Center, Hackensack University Medical Center, University of California, Irvine

#Research Funding #T-cell Acute Lymphoblastic Leukemia + Show 8 more

Abstract
Full-Text
Similar Papers

Abstract

Phase II Study of Hyper-CVAD Plus Nelarabine in Previously Untreated Adult T-Cell Acute Lymphoblastic Leukemia and T-Lymphoblastic Lymphoma

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Blood

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.